MBLY vs PATH

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 08, 2026

MBLY

44.0
AI Score
VS
MBLY Wins

PATH

37.4
AI Score

Investment Advisor Scores

MBLY

44score
Recommendation
HOLD

PATH

37score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric MBLY PATH Winner
Forward P/E 15.1976 22.8311 MBLY
PEG Ratio 0.2533 0.6519 MBLY
Revenue Growth 0.4% 17.3% PATH
Earnings Growth 99.7% 105.7% PATH
Tradestie Score 44.0/100 37.4/100 MBLY
Profit Margin -201.5% 19.6% PATH
Beta 1.00 1.00 Tie
AI Recommendation HOLD SELL MBLY

Relative Price Performance (Last 90 Days)

MBLY 1M: -6.3% · 3M: -13.9% PATH 1M: -9.9% · 3M: +29.1%

Current Technical Phase

MBLY

Markdown
Sell / avoid

Price below a falling SMA50 (slope -2.0%), weak momentum, RSI 43

RSI (14): 43.0 · Price: $8.25

PATH

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 39

RSI (14): 38.8 · Price: $13.75

Fundamentals Snapshot

Metric MBLY PATH
Market Cap
Forward P/E 17.0 18.0
Trailing P/E 20.1
Revenue (TTM)
Revenue Growth 0.0% 0.1%
Gross Margin 0.5% 0.8%
Operating Margin -0.1% 0.1%
EPS -4.97 0.69
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, MBLY is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.